Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-01-16

FDA Approved: TRIENTINE HYDROCHLORIDE — Original Application (Navinta LLC)

View source ↗

Summary

FDA approved Navinta LLC's original application for trientine hydrochloride (a generic drug) via ANDA. This drug is used to treat Wilson disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRIENTINE HYDROCHLORIDE (Trientine hydrochloride)

Snippet

ORIG AP for TRIENTINE HYDROCHLORIDE (TRIENTINE HYDROCHLORIDE)